Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities
- PMID: 974878
- DOI: 10.1139/y76-069
Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities
Abstract
The effects of viloxazine, a clinically effective antidepressant, on noradrenaline (NA) and 5-hydroxytryptamine (5-HT) uptake and various related pharmacological activities were determined and compared to those of the tricyclic antidepressants desimipramine, imipramine, and amitriptyline. Viloxazine inhibitied [3H]NA uptake in the mouse and rat heart, being maximally about one half as potent as imipramine with a similar onset, but shorter duration of action than imipramine. The drug did not inhibit [3H]NA uptake in rat medulla or hypothalamus in contrast to desimipramine and imipramine, but it did alter [3H]NA metabolites in a similar manner. Viloxazine, like desimipramine, was a weak blocker of mouse brain 5-HT uptake, but differed from desimipramine as it poteniated 5-HT-mediated functions in the mouse and rat, as did imipramine and amitriptyline, the latter drugs being relatively potent blockers of 5-HT uptake. Viloxazine potentiated the L-DOPA behavioural syndrome in the mouse, antagonized reserpine-induced ptosis and hypothermia in the mouse, and inhibited gastric acid secretion in the rat, but was less potent than the tricyclic antidepressants. No appreciable in vivo inhibition of monoamine oxidase (EC 1.4.3.4.) activity in the mouse was exhibited. Like imipramine, the drug potentiated the ocular effects of L-adrenaline in the rabbit. It was similar to imipramine in potency in potentiating the apomorphine-induced gnawing in the mouse. The drug antagonized oxotremorine-induced hypothermia in the mouse but differed from the tricyclic antidepressants in not exhibiting the anticholinergic effects of blocking the tremors, salivation and lacrimation. Thus, viloxazine exhibits activities related to the biogenic amines both similar to and different from the tricyclics desimipramine, imipramine, and amitriptyline. These actions appear to be of relevance with respect to the antidepressant action of this drug.
Similar articles
-
Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities.Psychopharmacology (Berl). 1976 May 5;47(1):33-41. doi: 10.1007/BF00428698. Psychopharmacology (Berl). 1976. PMID: 1085452
-
Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies.Gen Pharmacol. 1982;13(5):381-91. doi: 10.1016/0306-3623(82)90103-3. Gen Pharmacol. 1982. PMID: 6890919
-
Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo.Eur J Pharmacol. 1978 Dec 1;52(3-4):367-74. doi: 10.1016/0014-2999(78)90291-1. Eur J Pharmacol. 1978. PMID: 729646
-
Viloxazine: a review of the literature.Int Pharmacopsychiatry. 1980;15(2):118-23. doi: 10.1159/000468422. Int Pharmacopsychiatry. 1980. PMID: 7002831 Review.
-
Effects of antidepressants on monoamine transporters.Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(2-3):193-216. doi: 10.1016/0278-5846(88)90037-1. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 2898799 Review.
Cited by
-
Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.Drugs. 1977 Jun;13(6):401-21. doi: 10.2165/00003495-197713060-00001. Drugs. 1977. PMID: 324751 Review. No abstract available.
-
Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon.Psychopharmacology (Berl). 1982;76(3):212-7. doi: 10.1007/BF00432547. Psychopharmacology (Berl). 1982. PMID: 6808538
-
Effects of viloxazine on cortical neurone responses to monoamines and acetylcholine [proceedings].Br J Pharmacol. 1977 Mar;59(3):460P. Br J Pharmacol. 1977. PMID: 843706 Free PMC article. No abstract available.
-
Potentiation of responses to monoamines by antidepressants after destruction of monoamine afferents.Br J Pharmacol. 1979 Mar;65(3):501-10. doi: 10.1111/j.1476-5381.1979.tb07858.x. Br J Pharmacol. 1979. PMID: 311665 Free PMC article.
-
New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties.J Exp Pharmacol. 2020 Aug 25;12:285-300. doi: 10.2147/JEP.S256586. eCollection 2020. J Exp Pharmacol. 2020. PMID: 32943948 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources